Cardiothoracic & vascular anesthesia

Acute normovolemic hemodilution and cardiac surgery-associated acute kidney injury: a retrospective cohort study

Can J AnaesthPublished Retrospective cohort study

Main finding · Postoperative RRTResult — go to the resultRelative risk 0.63 95% CI 0.43–0.92

Authors' conclusion

In elective cardiac surgery, ANH was associated with reduced postoperative RRT and allogeneic transfusion requirements; however, residual confounding may persist, requiring confirmation in future studies.

Study context

Population
Patients undergoing elective cardiac surgery, JMDC Hospital database, Japan, 1 April 2016 to 31 May 2023
Participants
19,387 patients
Exposure
Acute normovolemic hemodilution (ANH) vs no ANH in elective cardiac surgery
  • ANHn = 1,644
  • non-ANHn = 1,639reference
Outcome
Initiation of renal replacement therapy (RRT) within 7 days postoperatively (cardiac surgery-associated acute kidney injury (CSA-AKI))
Follow-up
7 days postoperatively
Methodological detailsmarginal structural models with standardized mortality ratio weighting based on the propensity score, JMDC Hospital database
  • Marginal structural models with standardized mortality ratio weighting based on the propensity score
  • JMDC Hospital database

Main finding

Postoperative RRT

Relative risk

0.63

95% CI 0.43–0.92

P = 0.02

Events by group

ANH vs non-ANH
RR 0.63 (95% CI 0.43–0.92); P = 0.02

As reported in the abstract

Observational data: associations, not effects.

Secondary outcomes

Allogeneic blood transfusion units on the day of surgery

Fewer units required in the ANH group

In-hospital mortality

No significant difference between groups

Original publication

Acute normovolemic hemodilution and cardiac surgery-associated acute kidney injury: a retrospective cohort study. Can J Anaesth. Published 15 April 2026. doi:10.1007/s12630-026-03100-y

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.